Minimize upfront costs
related to chemistry, manufacturing, and controls (CMC)
Increase precision
in the formulations that are developed and tested, keeping you in control of your molecule's development
Reduce time
to first-in-human studies, so you can achieve the data you need and stay on-course to proof-of-concept
How is Translational Pharmaceutics® applied to drug development?
How to use Translational Pharmaceutics® to advance your next early development program
Beyond optimizing drug products, see how else Translational Pharmaceutics® can be applied to drug programs in these applications.
Image
- Translational Pharmaceutics® for accelerating first-in-human, Phase I testing
Reach a pivotal milestone with our phase-specific drug product to test the safety and tolerability of your drug.
- AI-enhanced formulation development within Translational Pharmaceutics®
Discover our new proprietary AI solution, combining Quotient Sciences intelligence with the power of AI, to achieve formulation decisions up to 50% faster.
- Translational Pharmaceutics® for drug product optimization in Phase Ib/IIa studies
Simplify reformulation after Phase I and beyond to manage product lifecycle, ensure continued innovation, and meet trial success.
- Translational Pharmaceutics® for more efficient, integrated human ADME studies
Whether for New Drug Applications (NDA) or in parallel with Phase II / proof-of-concept studies, we integrate services to ensure better ADME study outcomes.